“COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA”., Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. Page e2021034, Apr. 2021, doi: 10.4084/MJHID.2021.034.